220 related articles for article (PubMed ID: 31524005)
21. Extracellular traps and PAD4 released by macrophages induce citrullination and auto-antibody production in autoimmune arthritis.
El Shikh MEM; El Sayed R; Nerviani A; Goldmann K; John CR; Hands R; Fossati-Jimack L; Lewis MJ; Pitzalis C
J Autoimmun; 2019 Dec; 105():102297. PubMed ID: 31277965
[TBL] [Abstract][Full Text] [Related]
22. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
[TBL] [Abstract][Full Text] [Related]
23. Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis.
Gómez-Bañuelos E; Shi J; Wang H; Danila MI; Bridges SL; Giles JT; Sims GP; Andrade F; Darrah E
Arthritis Rheumatol; 2022 Nov; 74(11):1746-1754. PubMed ID: 35675168
[TBL] [Abstract][Full Text] [Related]
24. Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.
Lloyd KA; Wigerblad G; Sahlström P; Garimella MG; Chemin K; Steen J; Titcombe PJ; Marklein B; Zhou D; Stålesen R; Ossipova E; Lundqvist C; Ekwall O; Rönnelid J; Mueller DL; Karlsson MCI; Kaplan MJ; Skriner K; Klareskog L; Wermeling F; Malmström V; Grönwall C
Front Immunol; 2018; 9():3033. PubMed ID: 30662440
[TBL] [Abstract][Full Text] [Related]
25. Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen.
Auger I; Martin M; Balandraud N; Roudier J
Arthritis Rheum; 2010 Jan; 62(1):126-31. PubMed ID: 20039406
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies to PAD4 and BRAF in rheumatoid arthritis.
Auger I; Charpin C; Balandraud N; Martin M; Roudier J
Autoimmun Rev; 2012 Sep; 11(11):801-3. PubMed ID: 22349616
[TBL] [Abstract][Full Text] [Related]
27. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis.
Kolfenbach JR; Deane KD; Derber LA; O'Donnell CI; Gilliland WR; Edison JD; Rosen A; Darrah E; Norris JM; Holers VM
Arthritis Rheum; 2010 Sep; 62(9):2633-9. PubMed ID: 20496417
[TBL] [Abstract][Full Text] [Related]
28. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.
Darrah E; Rosen A; Giles JT; Andrade F
Ann Rheum Dis; 2012 Jan; 71(1):92-8. PubMed ID: 21859690
[TBL] [Abstract][Full Text] [Related]
29. Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14
Okamato Y; Ghosh T; Okamoto T; Schuyler RP; Seifert J; Charry LL; Visser A; Feser M; Fleischer C; Pedrick C; August J; Moss L; Bemis EA; Norris JM; Kuhn KA; Demoruelle MK; Deane KD; Ghosh D; Holers VM; Hsieh EWY
J Autoimmun; 2021 Feb; 117():102581. PubMed ID: 33310262
[TBL] [Abstract][Full Text] [Related]
30. Reduced Anti-Histone Antibodies and Increased Risk of Rheumatoid Arthritis Associated with a Single Nucleotide Polymorphism in PADI4 in North Americans.
Mergaert AM; Bawadekar M; Nguyen TQ; Massarenti L; Holmes CL; Rebernick R; Schrodi SJ; Shelef MA
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242568
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis.
Darrah E; Giles JT; Davis RL; Naik P; Wang H; Konig MF; Cappelli LC; Bingham CO; Danoff SK; Andrade F
Front Immunol; 2018; 9():2696. PubMed ID: 30515171
[No Abstract] [Full Text] [Related]
32. Thioredoxin Modulates Protein Arginine Deiminase 4 (PAD4)-Catalyzed Citrullination.
Nagar M; Tilvawala R; Thompson PR
Front Immunol; 2019; 10():244. PubMed ID: 30853960
[TBL] [Abstract][Full Text] [Related]
33. Peptidylarginine deiminase-4: Medico-formulative strategy towards management of rheumatoid arthritis.
Thirugnanasambandham I; Radhakrishnan A; Kuppusamy G; Kumar Singh S; Dua K
Biochem Pharmacol; 2022 Jun; 200():115040. PubMed ID: 35436466
[TBL] [Abstract][Full Text] [Related]
34. PAD4 Immunization Triggers Anti-Citrullinated Peptide Antibodies in Normal Mice: Analysis With Peptide Arrays.
Hemon MF; Lambert NC; Arnoux F; Roudier J; Auger I
Front Immunol; 2022; 13():840035. PubMed ID: 35432329
[TBL] [Abstract][Full Text] [Related]
35. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types.
Arnoux F; Mariot C; Peen E; Lambert NC; Balandraud N; Roudier J; Auger I
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10169-E10177. PubMed ID: 29109281
[TBL] [Abstract][Full Text] [Related]
36. Anti-Protein-Arginine Deiminase 4 IgG and IgA Delineate Severe Rheumatoid Arthritis.
Martinez-Prat L; Martinez-Taboada V; Santos C; Lopez-Hoyos M; Mahler M
Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140588
[TBL] [Abstract][Full Text] [Related]
37. Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.
Li B; Li P; Bi L
Clin Rheumatol; 2020 Mar; 39(3):899-907. PubMed ID: 31758423
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis.
Zhao J; Zhao Y; He J; Jia R; Li Z
J Rheumatol; 2008 Jun; 35(6):969-74. PubMed ID: 18398945
[TBL] [Abstract][Full Text] [Related]
39. Alleviation of arthritis through prevention of neutrophil extracellular traps by an orally available inhibitor of protein arginine deiminase 4.
Gajendran C; Fukui S; Sadhu NM; Zainuddin M; Rajagopal S; Gosu R; Gutch S; Fukui S; Sheehy CE; Chu L; Vishwakarma S; Jeyaraj DA; Hallur G; Wagner DD; Sivanandhan D
Sci Rep; 2023 Feb; 13(1):3189. PubMed ID: 36823444
[TBL] [Abstract][Full Text] [Related]
40. Antibodies targeting protein-arginine deiminase 4 (PAD4) demonstrate diagnostic value in rheumatoid arthritis.
Martinez-Prat L; Lucia D; Ibarra C; Mahler M; Dervieux T
Ann Rheum Dis; 2019 Mar; 78(3):434-436. PubMed ID: 30297325
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
